Bone Biologics Corporation Financial Ratios — BBLG Stock

Profitability (USD)

	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Return on Common Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	-23.71	-202.15	-128.71	-70.17
Return on Assets (%)	- -	-517	-2,302.39	-942.22	-482.52	-639.23	-11,838.26	-48.26	-19.57	-146.3	-108.23	-64.38
Return on Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Invested Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Gross Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EBITDA Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Operating Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Incremental Operating Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Pretax Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Profit Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Net Income to Common Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Dvd Payout Ratio (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	-23.71	-202.15	-128.71	-70.17

Credit (USD)

Credit Ratios API ChatGPT

	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Total Debt	7	5	9	8	9	11	12	- -	- -	- -	- -	- -
ST Debt	4	- -	1	- -	9	- -	12	- -	- -	- -	- -	- -
LT Debt	4	5	8	8	- -	11	- -	- -	- -	- -	- -	- -
Total Debt/EBITDA	-2.43	-0.42	-0.43	-3.13	-3.22	-4.63	-14.21	- -	- -	- -	- -	- -
Net Debt/EBITDA	-1.54	-0.33	-0.4	-2.87	-2.88	-4.62	-14.21	6.05	2.06	0.32	0.79	1.65
Total Debt/EBIT	-2.43	-0.42	-0.43	-3.13	-3.22	-4.63	-14.21	- -	- -	- -	- -	- -
Net Debt/EBIT	-1.54	-0.33	-0.4	-2.87	-2.88	-4.62	-14.21	6.05	2.06	0.32	0.79	1.65
EBITDA to Interest Expense	-2.15	-6.41	-6.43	-0.59	-2.27	-2.51	-0.83	-1.37	- -	- -	- -	- -
EBITDA-CapEx/Interest Expense	-2.15	-6.41	-6.43	-0.59	-2.27	-2.51	-0.83	-1.37	- -	- -	- -	- -
EBIT to Interest Expense	-2.15	-6.41	-6.43	-0.59	-2.27	-2.51	-0.83	-1.37	- -	- -	- -	- -
Interest Expense	1	2	3	4	1	1	1	1	- -	- -	- -	- -
Common Equity/Total Assets	-96.78	-367.27	-1,192.87	-1,055.2	-826.18	-38,497.49	- -	98.5	70.01	77.76	90.22	92.78
Long-Term Debt/Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Long-Term Debt/Capital (%)	101.09	-849.51	1,893.96	-4,953.58	- -	-2,067.13	- -	- -	- -	- -	- -	- -
Long-Term Debt/Total Assets (%)	95.39	328.59	1,078.68	1,034.32	- -	36,721.06	- -	- -	- -	- -	- -	- -
Total Debt/Equity (%)	-197.5	-89.47	-104.77	-98.02	-104.67	-95.39	-85.62	- -	- -	- -	- -	- -
Total Debt/Capital (%)	202.57	-849.51	2,194.46	-4,953.58	2,239.78	-2,067.13	-595.21	- -	- -	- -	- -	- -
Total Debt/Total Assets (%)	191.15	328.59	1,249.82	1,034.32	864.79	36,721.06	- -	- -	- -	- -	- -	- -
Net Debt to Equity	-125.54	-69.84	-97.36	-89.8	-93.56	-95.18	-85.62	-101.52	-126.75	-104.14	-95.45	-99.2
Net Debt/Capital (%)	491.54	-231.56	-3,683.61	-880.35	-1,453.28	-1,975.61	-595.21	6,681.45	473.81	2,517.78	-2,097.53	-12,340.54
EBITDA	-3	-12	-20	-3	-3	-2	-1	-1	-4	-9	-4	-3
EBITDA-CapEx	-3	-12	-20	-3	-3	-2	-1	-1	-4	-9	-4	-3
Operating Income (Loss)	-3	-12	-20	-3	-3	-2	-1	-1	-4	-9	-4	-3

Liquidity (USD)

Liquidity Ratios API ChatGPT

	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Cash Ratio	0.69	0.52	0.41	0.72	0.1	0.04	- -	66.81	2.96	3.64	8.8	12.74
Current Ratio	0.98	0.72	0.47	0.83	0.11	0.05	- -	66.81	3.33	4.5	10.22	13.85
Quick Ratio	0.71	0.68	0.59	0.72	0.1	0.04	- -	66.81	3.19	4.04	8.8	12.77
CFO/Avg Current Liab	- -	-1.18	-4.02	-2.7	-0.77	-0.64	-0.06	-0.18	-2.69	-5.66	-6.82	-6.76
Common Equity/Total Assets	-96.78	-367.27	-1,192.87	-1,055.2	-826.18	-38,497.49	- -	98.5	70.01	77.76	90.22	92.78
Long-Term Debt/Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Long-Term Debt/Capital (%)	101.09	-849.51	1,893.96	-4,953.58	- -	-2,067.13	- -	- -	- -	- -	- -	- -
Long-Term Debt/Total Assets (%)	95.39	328.59	1,078.68	1,034.32	- -	36,721.06	- -	- -	- -	- -	- -	- -
Total Debt/Equity (%)	-197.5	-89.47	-104.77	-98.02	-104.67	-95.39	-85.62	- -	- -	- -	- -	- -
Total Debt/Capital (%)	202.57	-849.51	2,194.46	-4,953.58	2,239.78	-2,067.13	-595.21	- -	- -	- -	- -	- -
Total Debt/Total Assets (%)	191.15	328.59	1,249.82	1,034.32	864.79	36,721.06	- -	- -	- -	- -	- -	- -
CFO/Total Liabilities	-36.64	-49.06	-80.84	-36.23	-42.59	-27.32	-3.12	-1,229.71	-139.99	-1,149.37	-1,092.08	-642.91
CFO/CapEx	-231.55	-7,035.28	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Altman's Z-Score	-7.03	-49.52	-200.68	-114.75	-101.57	-3,327.93	- -	95.35	-12.06	-35.95	-28.94	-18.28

Working Capital (USD)

Working Capital Ratios API ChatGPT

	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Accounts Receivable Turnover

- -

Days Sales Outstanding

- -

Inventory Turnover

- -

Days Inventory Outstanding

- -

Accounts Payable Turnover

- -

Accounts Payable Turnover Days

- -

Cash Conversion Cycle

- -

Inventory to Cash Days

- -

Inventories

- -

Raw Materials

- -

Work In Process

- -

Finished Goods

- -

Other Inventory

- -

Enterprise Value (USD)

Enterprise Value API ChatGPT

	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Market Capitalization	- -	- -	13	8	45	- -	12	18	2	2	3	3
- Cash & Cash Equivalents	3	1	1	1	1	- -	- -	7	8	3	3	5
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	7	5	9	8	9	11	12	- -	- -	- -	- -	- -
Enterprise Value	5	4	21	16	53	11	24	12	-6	-1	-1	-3
Total Capital	4	-1	- -	- -	- -	-1	-2	7	6	3	3	5
Total Debt/Capital (%)	202.57	-849.51	2,194.46	-4,953.58	2,239.78	-2,067.13	-595.21	- -	- -	- -	- -	- -
Total Debt / EV	1.57	1.28	0.42	0.53	0.17	1	0.49	- -	- -	- -	- -	- -
EV/Sales	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Cash Flow to Firm	- -	- -	- -	14.3	- -	- -	42.19	- -	- -	- -	- -	- -
EV/Free Cash Flow to Firm	- -	- -	- -	14.3	- -	- -	42.19	- -	- -	- -	- -	- -
Diluted Market Cap	- -	- -	13	7	8	- -	3	8	1	1	1	2
Diluted Enterprise Value	5	4	21	15	17	11	15	1	-6	-2	-2	-4
EV per Share	5,193.65	4,438.08	19,553.48	13,022.39	7,161.16	1,325.49	2,832.05	1,608.11	- -	- -	- -	- -
TTM Sales	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
TTM EBITDA	-3	-12	-20	-3	-3	-2	-1	-1	-4	-9	-4	-3
TTM Operating Income	-3	-12	-20	-3	-3	-2	-1	-1	-4	-9	-4	-3
TTM Cash Flow to Firm	-1	-2	-4	1	-3	-2	1	- -	-4	-10	-4	-3
TTM Free Cash Flow to Firm	-1	-2	-4	1	-3	-2	1	- -	-4	-10	-4	-3

Multiples (USD)

Valuation Multiples API ChatGPT

	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Price/Free Cash Flow	- -	- -	-1.71	-2.19	-2.06	- -	-6.89	-6.51	-0.34	-0.12	-0.35	-0.63
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Enterprise Value	5	4	21	16	53	11	24	12	-6	-1	-1	-3
Low Price	- -	- -	5,970	3,030	1,531.53	- -	900.9	564.57	128.1	17.46	4.8	1.3
EV/Sales	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings Average	- -	- -	-0.49	-1.62	-1.71	- -	-1.61	-5.62	-5.8	-0.51	-0.72	-1.4
Price/Earnings High	- -	- -	-0.62	-2.71	-2.55	- -	-1.66	-10.05	-26.14	-1.41	-2.34	-2.92
Price/Earnings Low	- -	- -	-0.24	-0.46	-0.48	- -	-1	-1.11	-0.69	-0.09	-0.3	-0.49
Price/Book Value	- -	- -	-1.55	-0.97	-5.18	- -	-0.91	2.77	0.27	0.83	0.8	0.48
Price/Book Value Average	- -	- -	-1.56	-1.51	-4.63	- -	-0.91	3.14	1.94	3.21	1.65	1.23
Price/Book Value High	- -	- -	-1.99	-2.53	-6.92	- -	-0.93	5.61	8.73	8.83	5.38	2.58
Price/Book Value Low	- -	- -	-0.77	-0.43	-1.31	- -	-0.56	0.62	0.23	0.53	0.68	0.43
Price/Tangible Book Value	- -	- -	-1.55	-0.97	-5.18	- -	-0.91	2.77	0.27	0.83	0.8	0.48
Price/Tangible Book Value Average	- -	- -	-1.56	-1.51	-4.63	- -	-0.91	3.14	1.94	3.21	1.65	1.23
Price/Tangible Book Value High	- -	- -	-1.99	-2.53	-6.92	- -	-0.93	5.61	8.73	8.83	5.38	2.58
Price/Tangible Book Value Low	- -	- -	-0.77	-0.43	-1.31	- -	-0.56	0.62	0.23	0.53	0.68	0.43
Price/Sales	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Sales Average	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Sales High	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Sales Low	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Cash Flow	- -	- -	-1.71	-2.19	-2.06	- -	-6.89	-6.51	-0.34	-0.12	-0.35	-0.63
Price/Cash Flow Average	- -	- -	-1.73	-3.43	-1.84	- -	-6.89	-7.36	-2.41	-0.48	-0.72	-1.61
Price/Cash Flow High	- -	- -	-2.2	-5.75	-2.75	- -	-7.11	-13.18	-10.88	-1.32	-2.33	-3.38
Price/Cash Flow Low	- -	- -	-0.85	-0.98	-0.52	- -	-4.26	-1.45	-0.29	-0.08	-0.29	-0.57
Price/Free Cash Flow Average	- -	- -	-1.73	-3.43	-1.84	- -	-6.89	-7.36	-2.41	-0.48	-0.72	-1.61
Price/Free Cash Flow High	- -	- -	-2.2	-5.75	-2.75	- -	-7.11	-13.18	-10.88	-1.32	-2.33	-3.38
Price/Free Cash Flow Low	- -	- -	-0.85	-0.98	-0.52	- -	-4.26	-1.45	-0.29	-0.08	-0.29	-0.57
EV/Sales Average	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Sales High	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Sales Low	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBITDA Average	-1.54	-0.33	-1.04	-7.7	-17.15	-4.62	-29.25	-12.64	-1.09	-0.67	-0.58	-0.4
EV/EBITDA High	-1.54	-0.33	-1.21	-10.97	-24.2	-4.62	-29.72	-27.39	-12.11	-2.4	-3.65	-2.65
EV/EBITDA Low	-1.54	-0.33	-0.71	-4.26	-6.91	-4.62	-23.52	2.37	1.69	0.16	0.23	0.93
EV/EBIT Average	-1.54	-0.33	-1.04	-7.7	-17.15	-4.62	-29.25	-12.64	-1.09	-0.67	-0.58	-0.4
EV/EBIT High	-1.54	-0.33	-1.21	-10.97	-24.2	-4.62	-29.72	-27.39	-12.11	-2.4	-3.65	-2.65
EV/EBIT Low	-1.54	-0.33	-0.71	-4.26	-6.91	-4.62	-23.52	2.37	1.69	0.16	0.23	0.93
Last Price	- -	- -	12,000	6,750	6,066.06	- -	1,456.46	2,536.92	151.14	27.12	5.64	1.45
High Price	- -	- -	15,450	17,700	8,100	- -	1,501.5	5,132.94	4,886.4	288.3	38.04	7.74
Enterprise Value Average	5	4	21	20	48	11	24	14	4	6	2	1
Enterprise Value High	5	4	25	29	68	11	25	30	44	23	15	9
Enterprise Value Low	5	4	15	11	19	11	19	-3	-6	-1	-1	-3

Shares Outstanding	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	2
Diluted Weighted Avg Shares	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	1
Basic Weighted Avg Shares	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	1
Revenue per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EBITDA per Share	-3,367.25	-13,413.46	-19,532.61	-2,429.69	-1,999.14	-1,208.58	-408.22	-349.74	-461.43	-214.98	-16.68	-2.75
Operating Income per Share	-3,367.57	-13,418.44	-19,533.28	-2,429.78	-1,999.2	-1,208.61	-408.22	-349.74	-461.43	-214.98	-16.68	-2.75
Basic EPS, GAAP	-4,949.01	-15,522.29	-24,764.28	-6,523.19	-3,173.64	-1,691.26	-902.86	-510.68	-186.91	-204.05	-16.26	-2.65
Basic EPS from Cont Ops	-4,949.01	-15,522.29	-24,764.28	-6,523.19	-3,173.64	-1,691.26	-902.86	-510.68	-186.91	-204.05	-16.26	-2.65
Diluted EPS, GAAP	-4,949.01	-15,522.29	-24,764.28	-6,523.19	-3,173.64	-1,691.26	-902.86	-510.68	-186.91	-204.05	-16.26	-2.65
Diluted EPS from Cont Ops	-4,949.01	-15,522.29	-24,764.28	-6,523.19	-3,173.64	-1,691.26	-902.86	-510.68	-186.91	-204.05	-16.26	-2.65
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	-3,082.35	-3,966.2	-7,012.29	-3,080.57	-2,940.46	-1,605.55	-211.25	-389.53	-449.06	-217.89	-16.31	-2.29
Free Cash Flow per Basic Share	-3,095.66	-3,966.76	-7,012.29	-3,080.57	-2,940.46	-1,605.55	-211.25	-389.53	-449.06	-217.89	-16.31	-2.29
Cash & Equivalents per Share	2,976.95	1,247.33	575.49	574.28	130.05	2.83	- -	928.81	709.42	33.99	6.75	2.97
Book Value per Share	-4,137.05	-6,354.66	-7,758.53	-6,984.88	-1,170.46	-1,392.59	-1,606.7	914.91	559.69	32.64	7.08	3
Tangible Book Value per Share	-4,137.05	-6,354.66	-7,758.53	-6,984.88	-1,170.46	-1,392.59	-1,606.7	914.91	559.69	32.64	7.08	3

Bone Biologics Corporation